Filing Flows › vTv Therapeutics (VTVT) › Recalls, complaints & regulation
vTv Therapeutics (VTVT): clinical trials
vTv Therapeutics (VTVT) beyond its filings: 2 active clinical trials.
vTv Therapeutics' latest quarter
vTv Therapeutics, Q1 2026: revenue $36.8M, operating margin 63.1%, net earnings $24.1M, operating cash flow $9.2M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does vTv Therapeutics have?
2 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.